Literature DB >> 31404660

Chronic venous obstruction during cardiac device revision: Incidence, predictors, and efficacy of percutaneous techniques to overcome the stenosis.

Giovanni Morani1, Bruna Bolzan2, Sergio Valsecchi3, Martina Morosato4, Flavio Luciano Ribichini1.   

Abstract

BACKGROUND: In recent years, upgrade and revision procedures of cardiac implantable electronic devices (CIEDs) have become increasingly frequent. Patency of the access veins is critical for procedural success.
OBJECTIVE: The purpose of this study was to determine the incidence of venous obstruction at the time of system revision, to identify predictors of venous stenosis, and to evaluate the efficacy and safety of percutaneous techniques for overcoming stenosis.
METHODS: All patients admitted to our division from January 2004 to January 2017 for CIED revision with the intent to add 1 or more leads were included. Each patient underwent ipsilateral contrast venography. The degree of venous stenosis was determined with the support of quantitative coronary angiography and categorized as significant (75%-90%), subocclusive (90%-99%), or occlusive (100%).
RESULTS: Of 227 patients, 61 (27%) showed a stenosis >75%. Different techniques were performed to overcome stenosis: direct vein access, distal venous puncture central to the stenosis, and percutaneous venoplasty in 25 (41%), 26 (43%) and 9 (15%) cases. respectively. All procedures were successful, without major complications. At multivariate analysis, having 3 leads before revision (odds ratio 0.444; 95% confidence interval 0.212-0.920; P = .029) and a previous system revision with lead insertion (odds ratio 0.323; 95% confidence interval 0.124-0.841; P = .021) were independent predictors of venous stenosis.
CONCLUSION: Chronic venous obstruction is a relatively frequent finding after CIED implantation. The number of implanted leads seems to be an independent predictor of venous obstruction. In case of stenosis, the preprocedural angiography-guided structured approach allowed preservation of both contralateral access and functioning leads.
Copyright © 2019 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac implantable electronic device upgrade; Chronic venous obstruction; Pacemaker and implantable cardioverter-defibrillator lead revision; Percutaneous transluminal venoplasty; Venous stenosis

Mesh:

Year:  2019        PMID: 31404660     DOI: 10.1016/j.hrthm.2019.08.012

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  5 in total

1.  Transvenous lead implantation via the accessory hemiazygos vein in superior vena cava occlusion.

Authors:  Peter H Waddingham; Adam S C Dennis; Anu Balan; Anthony W C Chow
Journal:  Heart Rhythm O2       Date:  2021-12-17

2.  Fusion cardiac resynchronization therapy in an left ventricular assist device patient from two devices and crossing leads: a case report.

Authors:  Anastasia D Egorova; Lieselot van Erven; Saskia L M A Beeres; Laurens F Tops
Journal:  Eur Heart J Case Rep       Date:  2021-08-17

Review 3.  New Insights in Central Venous Disorders. The Role of Transvenous Lead Extractions.

Authors:  Giulia Domenichini; Mathieu Le Bloa; Patrice Carroz; Denis Graf; Claudia Herrera-Siklody; Cheryl Teres; Alessandra Pia Porretta; Patrizio Pascale; Etienne Pruvot
Journal:  Front Cardiovasc Med       Date:  2022-02-23

4.  Severity and Extent of Lead-Related Venous Obstruction in More Than 3000 Patients Undergoing Transvenous Lead Extraction.

Authors:  Marek Czajkowski; Wojciech Jacheć; Anna Polewczyk; Jarosław Kosior; Dorota Nowosielecka; Łukasz Tułecki; Paweł Stefańczyk; Andrzej Kutarski
Journal:  Vasc Health Risk Manag       Date:  2022-08-17

5.  Wire countertraction for sheath placement through stenotic and tortuous veins: The "body flossing" technique.

Authors:  Jeffrey S Arkles; Prakash Goutham Suryanarayana; Mouhannad Sadek; Joshua M Cooper; David S Frankel; Fermin C Garcia; Jay Giri; Robert D Schaller
Journal:  Heart Rhythm O2       Date:  2020-04-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.